Lineage Cell Therapeutics Inc
(STU:BT3)
€
0.88
-0.042 (-4.54%)
Market Cap: 224.05 Mil
Enterprise Value: 181.35 Mil
PE Ratio: 0
PB Ratio: 4.27
GF Score: 65/100 Lineage Cell Therapeutics Inc (STU:BT3) Transcripts
- 1